- Home
- GALT vs GSRF Comparison
GALT vs GSRF Comparison
Compare GALT & GSRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
BUY
Current Price
$3.64
Company Overview
Basic Information| Metric | GALT | GSRF |
|---|---|---|
| Founded | 2000 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.0M | 298.8M |
| IPO Year | 2008 | 2025 |
Fundamental Metrics
Financial Performance| Metric | GALT | GSRF |
|---|---|---|
| Price | $3.64 | $10.27 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 234.5K | 73.2K |
| Earning Date | 11-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $184.52 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.03 | $9.96 |
| 52 Week High | $7.13 | $10.27 |
Technical Indicators
Market Signals| Indicator | GALT | GSRF |
|---|---|---|
| Relative Strength Index (RSI) | 42.14 | 80.62 |
| Support Level | $3.58 | $10.15 |
| Resistance Level | $4.30 | N/A |
| Average True Range (ATR) | 0.21 | 0.00 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 17.81 | 100.00 |
Price Performance
Historical Comparison GALT
GSRF
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About GSRF GSR IV Acquisition Corp. Class A ordinary share
GSR IV Acquisition Corp is a blank check company.